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Introduction {#sec1}
============

Bats are major reservoirs for viral zoonotic pathogens. Virus infections that are acute and highly aggressive in humans can be persistent and avirulent in bats ([@bib6]). An important contributor of virus tolerance by bats is thought to be the antiviral type I interferon (IFN-α/β) system ([@bib10]). Indeed, in some bats the IFN system has peculiar features and is under strong positive selection ([@bib8], [@bib48], [@bib71], [@bib73], [@bib75]). Bats may thus possess a fortified IFN system that suppresses viruses down to levels of persistence ([@bib10], [@bib48], [@bib69], [@bib73]).

Type I IFNs are a group of cytokines that encompass several subtypes, such as IFN-β, IFN-α 1 to 13, and some others ([@bib17]). Type III IFNs (IFN-λ 1, 2, 3) are similar, but unlike the systemic type I IFNs they act locally on epithelial cells ([@bib23]). IFN induction occurs by cellular sensing of viral RNA structures, resulting in the activation of IFN transcription factors, such as IRF3. The once-secreted IFNs bind to their receptor, activate the transcription factors STAT1/2 via the JAK kinases, and drive the expression of multiple IFN-stimulated genes (ISGs) with antiviral and immunomodulatory activity ([@bib55]).

Prototypical ISGs respond only to IFN signaling. However, there are ISGs additionally or even exclusively activated after virus sensing. Thus, the IFN response encompasses virus-response genes (IRF dependent), IFN-specific ISGs (STAT dependent), and universal ISGs (responding to both infection and IFNs) ([@bib53]).

Bats (order *Chiroptera*) are classified into the suborders *Yinpterochiroptera* (Syn. *Pteropodiformes*) and *Yangochiroptera* (Syn. *Vespertilioniformes*) ([@bib61]). Members of both suborders are infected by a wide range of virus species ([@bib6]). However, despite some progress, the contribution of the IFN response to their special ability to host viruses is not yet clarified. For *Yinpterochiroptera* such as *Pteropus alecto*, *vampyrus* or *Rousettus aegyptiacus* (all family *Pteropodidae*, or "megabats"), several studies had measured the global transcriptional response of cells to infection with, e.g., Ebola, Marburg, Nipah, or Hendra virus ([@bib25], [@bib34], [@bib68]) or to the IFN-inducing Newcastle Disease virus (NDV) ([@bib19]). By contrast, for the more diverse bat suborder *Yangochiroptera* (generically termed "microbats") there are just two virus-induced cell transcriptomes available ([@bib18], [@bib67]). However, the full virus response capability of bats remains uncharted because almost all cell response studies bar one ([@bib19]) with megabats and all studies with microbats employed wild-type viruses, which are weak IFN inducers. With respect to the response to IFN itself, there are expression profiles of cells from the megabat *P*. *alecto* ([@bib8], [@bib74]), and Shaw et al. recently conducted a pan-species comparison of IFN-stimulated cell transcriptomes, which included the megabat *P*. *vampyrus* and the *Yangochiroptera* microbat (family *Vespertilionidae*) *Myotis lucifugus* ([@bib56]).

Thus, previous studies on virus-induced or IFN-stimulated transcriptional profiles of cells overwhelmingly focused on megabats (family *Pteropodidae*) of the suborder *Yinpterochiroptera*. This suborder contains 7 bat families, whereas the *Yangochiroptera*, having separated around 60 million years ago, contain 14 families ([@bib61]). *Yangochiroptera* species host SARS-like coronaviruses ([@bib14]), rhabdoviruses and flaviviruses ([@bib6]), paramyxoviruses ([@bib13]), and bunyaviruses such as Crimean-Congo hemorrhagic fever-like virus ([@bib42]), Hantavirus ([@bib66]), or Rift Valley fever virus ([@bib6], [@bib44]). Nonetheless, for *Yangochiroptera* microbats there are (1) no studies on the transcriptomal cell responses to an IFN-inducing virus and (2) only one study on the IFN-stimulated gene expression profile ([@bib56]), which, however, focused on conserved ISGs. Moreover, to our knowledge a side-by-side, global comparison of early and late transcriptomes of cells in response to either virus or IFN is not available for any organism.

To fill these gaps, we devised a study for the *Yangochiroptera* microbat *Myotis daubentonii* (family *Vespertilionidae*). *M*. *daubentonii* is a carrier of lyssaviruses prevailing from Europe to Japan ([@bib39]). On the phylogenetical tree, it is maximally separated from the previously studied *Pteropodidae* megabats ([@bib61]). We stimulated *M*. *daubentonii* cells either with a strong IFN inducer virus or with type I IFN and measured global transcription at two different time points. Our results reveal several unique features like novel virus-response genes and an elevated number of paralogs of the antiviral ISG BST2. Unlike reported for megabats ([@bib48], [@bib75]) we could not detect different IFN-alpha subtypes or unusually high base levels of IFNs. Thus, besides exhibiting conserved antiviral responses and ISGs, several traits of the *Yangochiroptera* microbats are unique and not even observed for megabats.

Results and Discussion {#sec2}
======================

Outline of the Experiments to Measure Transcriptomes {#sec2.1}
----------------------------------------------------

The aim of our study was to obtain the full picture of the antiviral type I IFN response of the *Yangochiroptera* microbat representative *M*. *daubentonii*, using a kidney cell line (MyDauNi/2c) described previously ([@bib16], [@bib43]). IFNs have anti-proliferative activity, which is the reason why many cell lines have lost their ability to induce IFN and/or to respond to IFN over their passaging history ([@bib24]). MyDauNi/2c cells, however, exhibited the typical phosphorylation of STAT1 in response to exogenously added pan-species IFN-α B/D ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Moreover, STAT1 phosphorylation was downmodulated by Ruxolitinib, an established inhibitor of JAK1/2-mediated IFN signaling ([@bib60]). STAT1 phosphorylation and Ruxolitinib effect were comparable with the IFN-competent human A549 ([@bib33], [@bib65]) and the *R*. *aegytiacus* megabat cell line Ro6E-J ([@bib16]) that we used in parallel. These results demonstrate the capacity of the MyDauNi/2c cells to respond to IFN.

To elucidate the overall antiviral potency and the unimpeded ability to produce IFN in response to infection, we employed a mutant of Rift Valley fever virus that has its IFN suppressor NSs replaced by the *Renilla* luciferase gene (RVFVΔNSs::Renilla) ([@bib33]). RVFVΔNSs::Renilla is a strong inducer of type I IFNs, is sensitive to the antiviral action of IFNs, and able to infect cells from a wide range of vertebrates ([@bib33]). The built-in *Renilla* luciferase facilitates rapid and quantitative measurements of viral replication. Also, the *M*. *daubentonii* MyDauNi/2c cells could be infected with our reporter virus, permitting replication levels similar as in human A549 lung cell line or the fetal *R*. *aegytiacus* line Ro6E-J ([@bib28]) ([Figure S1](#mmc1){ref-type="supplementary-material"}B). Moreover, treatment with the IFN signaling inhibitor Ruxolitinib increased RVFVΔNSs::Renilla replication, whereas IFN-α suppressed it. Although the cell lines are from different organs, these results, taken together, demonstrate that our immortalized *Yangochiroptera*/*Vespertilionidae* cell line MyDauNi/2c possesses a fully functional IFN system that is comparable with the one of human and megabat cell lines.

[Figure 1](#fig1){ref-type="fig"}A gives an overview of the experimental setup. The MyDauNi/2c cells were either mock treated, infected with a strong IFN inducer (RVFV NSs mutant Clone 13) ([@bib4]), or treated with 1,000 U/ml IFN-α. Total cell RNAs were isolated at 6 and 24 h post infection, and rRNA-depleted cDNA libraries were sequenced with 60--70 million strand-specific single-end reads per sample ([Table S1](#mmc2){ref-type="supplementary-material"}). Of note, all experiments were performed in three independent, biological replicates.Figure 1Experiments and Analyses to measure *M*. *daubentonii* Transcriptomes in Response to Virus and IFN(A) Workflow.(B) Principal component analyses. The biological replicates of the transcriptomes of uninfected (mock), Clone 13-infected, and IFN-treated cells, sampled at two different time points, were analyzed and visualized by PCAGO (see text).

Around 70% of the quality-checked and trimmed reads could be uniquely mapped to the reference genome of the related *M*. *lucifugus* ([Table S2](#mmc3){ref-type="supplementary-material"}), using appropriate tools ([@bib9], [@bib31], [@bib54]). Based on pairwise comparisons of the mean values of the three replicates, protein-encoding genes that were induced or repressed by an absolute log2 fold change (FC) ≥ 2 and with an adjusted p ≤ 0.05 (DESeq2 (v1.16.1) \[[@bib38]\]) were defined as significantly responding to either Clone 13 infection or IFN. To test whether biological replicates cluster together, we performed various principal component analyses (PCA) using our PCAGO web service (<https://doi.org/10.1101/433078>). In general, and visualized by the PCA based on the top 500 variant genes ([Figures 1](#fig1){ref-type="fig"}B and [S2](#mmc1){ref-type="supplementary-material"}A), we found the biological replicates to cluster together. The PCA revealed that the transcriptomes of the 6-h post Clone 13 infection samples are closest to the mock samples and that the IFN-stimulated profiles of both time points are highly similar. The highest variance in the data (PC1 with 67,77%) can be explained by the large expression differences between the mock and Clone 13 6-h samples compared with the Clone 13 and IFN-stimulated 24-h samples. At 24 h, the Clone 13-infected cells show an expression pattern that is clearly distinguishable from all other conditions. One of the Clone 13 24-h replicates clustered somewhat apart from the other two replicates (see [Figure 1](#fig1){ref-type="fig"}B), but the difference between these accounts for only 3.3% (PC2; [Figure S2](#mmc1){ref-type="supplementary-material"}B) of the whole variation in the gene expression data when directly compared with the mock 24-h samples. A 2D- and a 3D-PCA-movie, visualizing the overall stable clustering and how the principal components change by adding more and more less-variant genes to the transformation, can be found in the online supplement ([Videos S1](#mmc4){ref-type="supplementary-material"} and [S2](#mmc5){ref-type="supplementary-material"}). CLARK classification ([@bib47]) and Krona visualization ([@bib45]) revealed ∼1% of the reads with high similarity to the RVFV reference genome in this specific sample, compared with 3%--4% in the other two replicates ([Figure S3](#mmc1){ref-type="supplementary-material"}). In addition to our reference-based analyses, we have created a comprehensive *de novo* transcriptome assembly for *M. daubentonii* by combining ([@bib15]) the output of various suitable assembly tools ([@bib3], [@bib20], [@bib36], [@bib70]) according to the results of Hölzer and Marz ([@bib76]).

Video S1. Animated 2d-PC, Related to Figure 1

Video S2: Animated 3d-PCA, Related to Figure 1

Virus-Responsive Genes {#sec2.2}
----------------------

At 6 h post infection with the IFN inducer virus Clone 13, 21 genes were upregulated ([Figures 2](#fig2){ref-type="fig"}A and 2B). Among these were prototypical, IRF3-driven genes (IFNB1, CCL5, CXCL10, IFIT1 to 3, OAS1, and OASL), and others reported to be expressed by infected cells (DDX58, DDX60, DHX58, IFIH1, IFI44, ISG15) ([@bib2], [@bib11], [@bib19], [@bib21], [@bib40], [@bib50], [@bib53]). By contrast, upregulated genes such as IRF7, MX1, MX2, OAS3, SAMD9, and USP18 are prototypical ISGs ([@bib52], [@bib56]) that most likely are activated by the Clone 13-induced IFN in the supernatant (see later discussion). Altogether the upregulated genes are commanding biological processes of the immediate-early innate response to viruses, as shown by GO term enrichment using the Piano package ([@bib63]) ([Figure S4](#mmc1){ref-type="supplementary-material"}A, upper panel).Figure 2*Myotis daubentonii* Genes Differentially Regulated in Response to Clone 13 Infection(A) Heatmap of log2-fold changes in infected cells as compared with mock infected cells. The displayed genes were filtered by an absolute log2-fold change of 2 and an adjusted p value \< 0.05. Genes that are similarly regulated at 6 and 24 h post infection are clustered together. Data are averages from three biological replicates. Genes missing a gene name and a function in the current Ensembl annotation of *M. lucifugus* were listed by their unique and abbreviated ID numbers: e.g., "ENSMLUG00000015795" was shortened to "15795."(B) Venn diagrams showing the numbers of significantly regulated mRNAs at the two time points of infection.

At 24 h post infection, 246 genes were upregulated and 13 genes were downregulated. All the genes from the 6-h time point are included in the 24-h-upregulated genes (see [Figures 2](#fig2){ref-type="fig"}A and 2B). Comparisons with the pan-species database of IFN-triggered transcriptomes ([@bib56]) identified conserved additional ISGs (besides the ones mentioned for the 6-h time point) such as, e.g., ADAR, BST2, various GBPs, HERC6, IFITM 2 and 3, IRF9, PARP12, PML, RSAD2, TRIM22, SOCS1, STAT1, STAT2, or ZBP1. SAMHD1, by contrast, was recently described as being IRF3 dependent in human, monkey, and porcine cells ([@bib72]). Among the late virus responders were also more unusual genes such as CSF2 or NEURL3. Both are weakly IFN stimulated in *Rattus norvegicus* but not in any other mammalian species ([@bib56]). In *M*. *daubentonii*, CSF2 is exclusively virus inducible (see below) and NEURL3 is strongly virus as well as (weakly) IFN inducible.

The genes upregulated at this later time point were functionally more diversified than the 6-h ones, as they promote adaptive immunity, apoptosis, and also RNA polymerase II activity, besides the innate immune response ([Figure S4](#mmc1){ref-type="supplementary-material"}A, lower panel). The genes downregulated at 24 h post infection were mostly involved in carbohydrate metabolism and protein transport.

All significantly up- or downregulated genes can be investigated with our Interactive Gene Observer search tool <https://www.rna.uni-jena.de/supplements/mda/report.html> which was was modified from the output of the Reporting Tools package ([@bib26]). Full gene tables and expression statistics for the individual biological replicates and all pairwise comparisons can be found in the electronic supplement, [Figure S5](#mmc1){ref-type="supplementary-material"}. Coverage of viral genome is documented in [Figure S6](#mmc1){ref-type="supplementary-material"}.

IFN-Responsive Genes {#sec2.3}
--------------------

When cells were treated for 6 h with IFN, 195 genes were strongly upregulated (i.e., substantially more than after 6 h of Clone 13 infection). No gene was downregulated ([Figures 3](#fig3){ref-type="fig"}A and 3B). The IFN-regulated genes encompassed prototypical (OAS1, ISG15, Mx1, IFIT3, BST2, DHX58) but also less known ISGs (BCL2L14, RNF213, ESIP1).Figure 3*Myotis daubentonii* Genes Differentially Regulated in Response to Type I IFN(A) Heatmap of log2-fold changes in IFN-treated cells as compared with mock infected cells. The displayed genes were filtered as described for [Figure 2](#fig2){ref-type="fig"}. Genes that are similarly regulated at 6 and 24 h post IFN are clustered together. Data are averages from three biological replicates. Genes missing a gene name and a function in the current Ensembl annotation of *M*. *lucifugus* were listed by their unique and abbreviated ID numbers: e.g., "ENSMLUG00000015795" was shortened to "15795."(B) Venn diagrams showing the numbers of significantly regulated mRNAs at the two time points of IFN treatment.

At 24 h, the number of upregulated genes was decreased to 106, of which 1 gene (PLA1A) was actually unique for this late time point. Moreover, just 1 gene (AHNAK2) is significantly downregulated at 24 h. Thus, *M*. *daubentonii* cells are capable of rapidly responding to IFN, and at the 24-h time point almost half of the stimulated genes were back to base levels. This transient character of the type I IFN response is in agreement with recent studies on cells from megabat (*P*. *alecto*) ([@bib8]), man ([@bib27]), and mouse ([@bib41]).

For the IFN-stimulated transcriptomes, predominant biological processes both at 6 and 24 h post infection encompassed antigen processing and presentation, antiviral defense, immune response, and NF-kB regulation ([Figure S4](#mmc1){ref-type="supplementary-material"}B). Additionally, at 6 h there are indications of both up- and downregulation of intracellular and transmembrane transport, and at 24 h oxidoreductase activity is mostly downregulated.

Genes Uniquely Regulated by Virus Infection {#sec2.4}
-------------------------------------------

To our knowledge, a kinetic and side-by-side comparison of virus-driven versus IFN-driven host cell transcriptomes was not reported for any mammalian species so far. Therefore, beyond the bat-specific aspects this study was initiated for, we took advantage of our database to filter out genes that are uniquely regulated by either treatment. To address this issue, we compared gene expression at the 6- and 24-h time points of Clone 13 infection and IFN treatment with each other. Overall, running the two transcriptomes next to each other showed once more that at 6 h Clone 13 infection stimulated less genes (denominated as being "downregulated") than 6-h IFN treatment ([Figures 4](#fig4){ref-type="fig"}A and 4B). We could identify some genes that are upregulated exclusively by Clone 13, most prominently the prototypical, IRF3-driven virus-response gene IFNB1. When restricting ourselves to genes that were not at all regulated by IFN but upregulated by a log2 of more than 3 by virus (i.e., stricter than the log2-fold change of 2 filter we had set for the heatmaps), a similar virus-only response behavior was exhibited by other cytokines such as, e.g., CCL2, CCL4, IFNL3 (IFN-λ3), and CSF2, and also by more untypical genes such as CH25H, ICAM1, and STEAP4. [Figure 4](#fig4){ref-type="fig"}C shows RNA-seq data as expression box plots to illustrate the exclusive virus-response behavior in *M*. *daubentonii* cells.Figure 4Genes Differentially Regulated by Virus Infection versus Type I IFN(A) Heatmap of log2-fold changes in IFN-treated cells as compared with Clone 13-infected cells. The displayed genes were filtered by an absolute log2-fold change of 2 and an adjusted p value \< 0.05. Genes that are similarly regulated at 6 and 24 h post IFN are clustered together. Data are averages from three biological replicates. Genes missing a gene name and a function in the current Ensembl annotation of *M*. *lucifugus* were listed by their unique and abbreviated ID numbers: e.g., "ENSMLUG00000015795" was shortened to "15795."(B) Venn diagrams showing the numbers of significantly regulated mRNAs at the two time points of IFN treatment.(C) Expression box plots of selected mRNAs that responded significantly to Clone 13 treatment but not to control and IFN-stimulated conditions. The plots show the DESeq2-normalized expression values for each condition and biological replicate. Graphs show mean values and standard deviations from the three biological replicates.

Not all these genes are known as pure virus responders. Therefore, we verified our findings by RT-qPCR for the strongest early virus responders (IFNB1, CCL4, IFNL3, CH25H, STEAP4) and compared with the human system. Although being a late responder, CH25H (cholesterol 25-hydroxylase) is included because it is a powerful, broad-spectrum virus inhibitor. Human A549 and MyDauNi cells were infected with Clone 13, treated with IFN, or left untreated, and samples were taken 6 and 24 h later. Moreover, to exclude any potential cross talk by virus-triggered IFN, we kept in parallel cells under the JAK/STAT signaling inhibitor Ruxolitinib. In both the human and the *Myotis* cells, Ruxolitinib expectedly inhibited STAT1 phosphorylation and upregulation of the prototypical IFN-dependent ISG Mx1 ([Figure S7](#mmc1){ref-type="supplementary-material"}). The RT-qPCR data shown in [Figure 5](#fig5){ref-type="fig"} demonstrate that IFNB1, CCL4, IFNL3, and CH25A are exclusively virus induced with no stimulation whatsoever by IFN. (Of note, a downmodulation of IFNB1 at 24 h post infection was detected by RT-qPCR but not by the less sensitive NGS \[see [Figure 2](#fig2){ref-type="fig"}\].) This was true for both the human and the *M*. *daubentonii* cells, indicating a conserved behavior. STEAP4 (six transmembrane epithelial antigen of prostate), by contrast, was identified as a virus-only response gene in *M*. *daubentonii* cells but unresponsive to both IFN and Clone 13 in human cells.Figure 5RT-qPCR Confirmation of Virus-Only Response GenesHuman A549 and *M*. *daubentonii* MyDauNi cells, treated or not with Ruxolitinib, were incubated with 1,000 U/ml IFN-α or infected with Clone 13 (MOI 5) for 6 or 24 h, respectively. Expression of IFNB1, CCL4, IFNL2/3 (A549)/IFNL3 (MyDauNi), CH25H, and STEAP4 were monitored by RT-qPCR. The graphs show the fold induction over mock, for the respective time point, with mean values and standard deviations from three independent replicates.

Literature and database searches were done to find information about these genes that we found to behave like IFNB1. As remarked earlier, the transcriptomes published so far were from either virus-infected or from IFN-treated cells but not from both in parallel. Thus, transcriptomes as well as most studies on individual ISGs could not clearly distinguish between primary (i.e., virus dependent) and secondary (virus-induced IFN) responses to infection, thus impeding a clear distinction of gene expressions that are unique for either of these triggers. Moreover, Ruxolitinib was not used before to systematically study IFN-independent cell responses to virus infection. Hence, we had aimed to clearly differentiate true virus-response genes from conventional ISGs indirectly activated by virus-induced IFN.

The chemokine CCL4 (Macrophage inflammatory protein-β; MIP1-β), an attractant of immune cells such as macrophages or natural killer cells, is not an ISG in humans or other mammals ([@bib56]). However, CCL4 was found to be upregulated after 24 h of infection with the IFN-inducing NDV in *P*. *vampyrus* megabat cells ([@bib19]). Our results show that this occurs independently of IFN signaling. Thus, we propose CCL4 to be an apparently conserved (humans, megabats, microbats) virus response gene.

The type III interferon IFNL3 (IFNL2/3 in humans) was shown to be stimulated by IRF3 or IRF7 as well as by Sendai virus infection in human ([@bib1], [@bib46]) and by NDV in *P*. *vampyrus* cells ([@bib19]). With regard to IFN responsiveness, there are no entries for mice, humans, and other mammals in the databases ([@bib7], [@bib52], [@bib56]). Our Ruxolitinib data demonstrate that also IFNL3 is a conserved virus-response gene.

CH25H is a powerful broad-spectrum inhibitor of virus entry ([@bib37], [@bib51]). It is not responsive to NDV infection in *P*. *vampyrus* cells ([@bib19]). CH25H is published as being weakly IFN stimulated in human (which we could not observe in our A549 cells), rat, horse, and dog; unresponsive to IFN in sheep, pigs and bats; and actually downregulated in cattle ([@bib56]). Thus, CH25H is a little conserved (and weak) ISG that we find in humans and *M*. *daubentonii* to be a novel and strong virus-response gene.

STEAP4 is a TNF-α- and IL1β-induced metalloreductase ([@bib32]). It is IFN stimulated in humans and pigs but not in any other mammalian species ([@bib56]). Interestingly, we observed a complete non-responsiveness to any stimulant in human A549 cells, whereas it was upregulated by Clone 13 infection in *M*. *daubentonii* cells. In *P*. *vampyrus*, by contrast, it is not among the virus-activated ([@bib19]).

Thus, taken together, we mapped the global responses of *M*. *daubentonii* to both virus infection and IFN treatment. Moreover, owing to our statistically robust datasets, early and late time points of sampling, and control experiments using Ruxolitinib, we could identify genes that are like IFNB1 exclusively upregulated by virus infection, either in both humans and *Myotis* (CCL4, IFNL3, CH25H) or only in *Myotis* (STEAP4).

Specific Features of the Microbat Responses {#sec2.5}
-------------------------------------------

A somewhat surprising finding was the low presence of type I IFN subtypes besides IFNB1. In fact, we could identify only a type I IFN gene with similarity to horse IFNW2 (IFN-ω2) as being modestly IFN stimulated at the 6-h time point, where it reached a log2 fold change of 2.23 and a significant p value (see [Figure 3](#fig3){ref-type="fig"}). Another detectable type I IFN subtype (although it did not reach the significance threshold) was a relative to human IFNA5. Also Shaw et al. did not list any type I IFN in their pan-mammal transcriptome study ([@bib56]), whereas studies in megabats ([@bib48], [@bib75]) showed an upregulation of IFN-α- or IFN-ω-like genes upon Sendai virus infection by RT-PCR. Moreover, Zhou et al. reported high base levels of several type I IFN subtypes in the megabat *P*. *alecto* ([@bib75]), which was observed neither for the megabat *R*. *aegyptiacus* ([@bib48]) nor by us in *M*. *daubentonii* microbat cells.

An interesting feature of our *M*. *daubentonii* data was the detection of multiple paralogs of Mx and BST2. In the genome of the related *M*. *lucifugus* we identified three and four copies of Mx and BST2, respectively. Based on the *M*. *lucifugus* reference genome, *M*. *daubentonii* significantly upregulated either all three (Mx) or all four (BST2) genes ([Figure 6](#fig6){ref-type="fig"}A). Mx (myxovirus resistance protein) is a large cytosolic GTPase with a broad antiviral spectrum ([@bib22]). Almost all investigated vertebrate species express multiple paralogs ([@bib22]). Bat Mx proteins (including Mx1 of *M*. *daubentonii*) were shown to confer antiviral activity ([@bib16]). BST2 (bone marrow stromal cell antigen 2), also called Tetherin, is an antiviral transmembrane protein tethering enveloped virus particles to the plasma membrane ([@bib12]). A search in the annotated genomes of mammals revealed that *Yangochiroptera*/*Vespertilionidae* such as *Myotis lucifugus*, *brandtii* und *davidii*, as well as *Eptesicus fuscus* harbor several copies of the BST2 gene, whereas *Miniopterus natalensis* (*Yangochiroptera*/*Miniopteridae*) seems to have just one copy ([Figure 6](#fig6){ref-type="fig"}B and data not shown). Using our *M*. *daubentonii* RNA-seq data, we were able to detect expression of four BST2 paralogs in the genome of *M*. *lucifugus*. However, two had an identical sequence (data not shown), so we confirm three BST2 paralogs with a differing sequence in the transcriptome of *M*. *daubentonii*. Thus, *Vespertilionidae* microbats are unique in harboring a multitude of BST2 paralogs, since all other species (except for sheep, which have two \[[@bib62]\]) have only one copy. Overall, our observations are that *Yangochiroptera*/*Vespertilionidae* microbats express a high number of paralogs of Mx and unexpectedly also BST2, two ISGs with a broad antiviral spectrum. This may indicate an increased capability to directly fend off virus infections.Figure 6BST2 Paralogs and PhylogenyWe identified four BST2 paralogous genes in the genome of *M*. *lucifugus* that served as a reference in this study. From the *de novo* transcriptome assembly of the *M*. *daubentonii* RNA-seq data, we were able to distinguish only three different BST2-like mRNAs.(A) The box plots show arithmetic means and standard deviations from the DESeq2-normalized expression values of the *M*. *daubentonii* RNA-seq reads, uniquely mapped to the *M*. *lucifugus* reference genome.(B) Phylogenetic tree of twelve selected mammalian BST2 genes and the four and three BST2 paralogs identified in the *M*. *lucifugus* genome or *M*. *daubentonii* transcriptome, respectively.

Comparison with Other Published Innate Immunity Bat Transcriptomes {#sec2.6}
------------------------------------------------------------------

As mentioned, previous transcriptional profiling studies of bats overwhelmingly used weak IFN inducer viruses or IFN and megabat cells, and only one study so far (again in megabats \[[@bib19]\]) used a truly IFN-inducing virus. Moreover, a global, side-by-side comparison between virus- and IFN-stimulated transcriptomes seems not to exist for any species, not even for humans. In addition to the points raised earlier on IFN subtypes and ISGs, we compared some of our findings with the distinctive results from previous bat studies.

Glennon et al. profiled the transcriptome of cells from the megabat *P*. *vampyrus* infected for 24 h with the IFN-inducing NDV ([@bib19]). They observed activation of IFNB1 and prototypical ISGs (e.g., DDX58, IFIH1, BST2, Mx1, or ISG15) and identified several novel ISGs, most prominently MORC3 (MORC family CW-type zinc finger 3). Subsequent RT-PCR analyses showed that this novel ISG was not consistently IFN dependent in cells from other bats but was NDV induced in all bat species, including the microbat *Myotis velifer incautus* ([@bib19]). In the pan-species IFN response comparisons of Shaw et al., MORC3 was identified as a core ISG ([@bib56]). Also, in our *M*. *daubentonii* transcriptomes, MORC3 was upregulated by IFN and Clone 13, although only weakly (see <https://www.rna.uni-jena.de/supplements/mda/report.html>). Interestingly, MORC3 is known as a restriction factor of herpes viruses ([@bib57]) but a pro-viral factor for influenza virus ([@bib64]).

De la Cruz Vera et al. identified for the megabat *P*. *alecto* several genes that were not previously reported as being ISGs, namely, EMC2, FILIP1, IL17RC, OTOGL, SLC10A2, SLC24A1, and RNASEL ([@bib8]). Our transcriptomes show that EMC2, FILIP1, IL17RC, OTOGL, and SLC24A1/2 are not ISGs in *M*. *daubentonii*, whereas RNASEL was confirmed. In fact, RNASEL is an ISG in most of the species investigated by Shaw et al. except for humans and chicken ([@bib56]), thus bolstering the conclusions of de la Cruz Vera et al.. Thus, the microbat ISG profile is distinct from the one of megabats.

Conclusions {#sec2.7}
-----------

Bats, which comprise about 20% of all living mammal species, have recently come into the focus of virus and innate immunity research. However, the group of "bats" is very heterogeneous and encompasses both *Yinpterochiroptera* and *Yangochiroptera*, which have diverged since approximately 60 million years ([@bib61]). For *Yangochiroptera* microbats, in contrast to megabats of the *Yinpterochiroptera* suborder, the IFN system is only poorly characterized. Here, we presented the time-dependent transcriptional profiles of *M*. *daubentonii* cells infected with a strong IFN inducer virus or treated with IFN. Our data revealed virus-triggered genes (CCL4, IFNL3, CH25H, STEAP4) that are not regulated by IFN itself, as well as the presence of multiple paralogs of directly antiviral ISGs such as Mx and BST2. CCL4 and IFNL3 attract immune cells and enhance local antiviral activity, respectively, and Mx, BST2, and CH25H are broad-spectrum virus inhibitors. Although our data are derived from a single cell line and may not be entirely generalizable, our analysis indicates that the *Yangochiroptera* microbat IFN system may exhibit features not observed for megabats or humans (STEAP4 as virus-response gene, at least 3 BST2 paralogs). Moreover, we report the absence of a series of megabat ISGs (EMC2, FILIP1, IL17RC, OTOGL, SLC24A1) and confirm a set of ISGs as being conserved also in *Yangochiroptera*. Also, in contrast to findings in megabat cells, we could not detect an increased copy number or upregulation of type I IFN genes other than IFNB1, or unusually high base levels of IFNs. Moreover, based on true biological replicates we offer statistically robust RNA-seq data on a time-resolved comparison between virus-induced and IFN-stimulated transcriptional responses of an IFN competent mammalian cell line.

Limitations of the Study {#sec2.8}
------------------------

Potential caveats of our paper are that (1) an immortalized *Myotis daubentonii* cell line was used, (2) the *Myotis daubentonii* cells are of kidney origin and their IFN response were compared with that of a human lung cell line, and (3) it is unknown how much the innate immune response of *Myotis* cells are representative for the entire suborder *Yangochiroptera*.

Methods {#sec3}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.

Data and Code Availability {#appsec1}
==========================

Our online search tool is available at <https://www.rna.uni-jena.de/supplements/mda/report.html>. The raw read data was deposited in the GEO database under accession number GEO: [GSE121301](ncbi-geo:GSE121301){#intref0030}. All intermediate files such as the quality-trimmed and rRNA-cleaned reads of all 18 samples, mappings, the extended genome annotation, and raw read counts were uploaded to the Open Science Framework under <https://doi.org/10.17605/OSF.IO/X9KAD>.

Supplemental figures and files are also found at <https://www.rna.uni-jena.de/supplements/mda/>.

<https://www.rna.uni-jena.de/supplements/mda/>.
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Document S1. Transparent Methods and Figures S1--S7Table S1. Overview of all RNA-Seq DataSets, Related to Figure 1All reads were quality checked with FASTQC and Prinseq. Ribosomal RNAs were removed by SortMeRNA. Shown are read statistics before and after trimming.Table S2. STAR Mapping Rates, Related to Figure 1
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